Hans-Jürgen Tietz
Hans-Jürgen Tietz
Thomas F Voigt
Thomas F Voigt
[Off label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure] [0.03%]
[肝移植后长期抗凝治疗中的超说明书用药——由于苯丙香豆素所致肝功能衰竭]
Thilo Bertsche,Reiner Fritz,Peter Sauer et al.
Thilo Bertsche et al.
Background: Drug therapy should be individualised according to criteria of efficacy, adverse effects, and treatment adherence. This is particularly important at the interface of inpatient and ambulatory care. Aspects of d...
Irene Krämer,Hans-Peter Lipp
Irene Krämer
Bevacizumab represents the first humanized monoclonal antibody with antiangiogenic properties which has been introduced in clinical oncology. The VEGF antagonist is used for the treatment of advanced colorectal cancer based on significant s...
Achim Weizel
Achim Weizel
An unfavourable constellation of plasma lipids, e.g., a high triglyceride concentration in combination with a low HDL cholesterol concentration, is a relevant risk factor for the development of arteriosclerosis and coronary heart disease. P...
[Pulmonary arterial hypertension. Therapy with the endothelin-1 receptor antagonist bosentan] [0.03%]
肺动脉高压的治疗：用内皮素受体拮抗剂波生坦治疗 pulmonary arterial hypertension. therapy with the endothelin-1 receptor antagonist bosentan)
Annemarie Musch
Annemarie Musch
Activation of the endothelin-1 system plays a key role in the pathogenesis of pulmonary arterial hypertension (PAH). The endothelin-1 receptor antagonist bosentan inhibits the action of endothelin-1 at both receptor subtypes (ET(A) and ET(B...
Susanne Heinzl
Susanne Heinzl
Annemarie Musch
Annemarie Musch
Heike Oberpichler-Schwenk
Heike Oberpichler-Schwenk
Susanne Wasielewski
Susanne Wasielewski